1834 Investment Advisors’s Sonoma Pharmaceuticals SNOA Stock Holding History

1834 Investment Advisors’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1	Closed	–	–	413
2022 Q2	$0	Hold	1	–	–	﹤0.01%	499
2022 Q1	$0	Hold	1	–	–	﹤0.01%	472
2021 Q4	$0	Hold	1	–	–	﹤0.01%	494
2021 Q3	$0	Hold	1	–	–	﹤0.01%	516
2021 Q2	$0	Hold	1	–	–	﹤0.01%	520
2021 Q1	$0	Hold	1	–	–	﹤0.01%	498
2020 Q4	$0	Hold	1	–	–	﹤0.01%	472
2020 Q3	$0	Hold	1	–	–	﹤0.01%	464
2020 Q2	$0	Hold	1	–	–	﹤0.01%	465
2020 Q1	$0	Hold	1	–	–	﹤0.01%	440
2019 Q4	$0	Hold	1	–	–	﹤0.01%	483
2019 Q3	$0	Hold	1	–	–	﹤0.01%	493
2019 Q2	$0	Hold	1	–	–	﹤0.01%	457
2019 Q1	$0	Hold	1	–	–	﹤0.01%	425
2018 Q4	$0	Hold	1	–	–	﹤0.01%	419
2018 Q3	$0	Hold	1	–	–	﹤0.01%	425
2018 Q2	$0	Hold	1	–	–	﹤0.01%	461
2018 Q1	$0	Hold	1	–	–	﹤0.01%	471
2017 Q4	$1K	Buy	+1	New	+$856	﹤0.01%	449

Other funds holding SNOA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HFS

HBC Financial Services Seattle, Washington $163M AUM 14.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

1834 Investment Advisors's SNOA Position: Q3 2022 in Review

1834 Investment Advisors sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2022, closing a stake of 1 share.

1834 Investment Advisors first reported a position in SNOA in Q4 2017 and held it in 19 quarters. The position peaked at $1K in Q4 2017. 16 funds tracked by Wall St. Rank hold SNOA as of Q3 2022.

1834 Investment Advisors reported no remaining Sonoma Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
1834 Investment Advisors sold 1 Sonoma Pharmaceuticals share in Q3 2022.
1834 Investment Advisors first reported a position in Sonoma Pharmaceuticals in Q4 2017 and held it in 19 quarters.
1834 Investment Advisors's Sonoma Pharmaceuticals position peaked at $1K in Q4 2017.
16 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2022.

Based on 1834 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.